2 Events related to a clinical picture of altered skin sensation such as sensitive skin, hyperesthesia, dysesthesia and paresthesia were reported by a higher proportion of participants, and at a higher rate, in the Wegovy HD arm (22%), compared to treatment with Wegovy 2.4 mg (6%) and placebo (0.3%)
My PCP did not have answers for severe PMS or unexplained weight gain
Pregnancy registry: There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to semaglutide (the active ingredient in Wegovy and Ozempic) during pregnancy
Managing Menstrual Changes While Taking GLP-1 Medications If you experience menstrual changes whilst taking GLP-1 medications, several practical strategies can help you manage these alterations effectively
Consultation with a registered dietitian experienced in weight management can provide personalized strategies for maintaining muscle mass while achieving weight loss goals on semaglutide
GLP-1 microdosing uses sub-therapeutic doses of Tirzepatide below the standard weight-loss range to deliver metabolic and appetite-regulating benefits with a significantly reduced side effect profile